FDA issued a Warning Letter to Baxter Healthcare Corp. on 1/17/2014 for a later inspection.
483 Baxalta US Nov 2004

483 Baxalta US Nov 2004

Gregory Dill FDA, Bruce Mccullough FDA$595.00 - Available Now

FDA investigators audited the Baxalta US - Round Lake, IL, United States facility and issued inspectional observations (via FDA 483) on 17 Nov 2004.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Nov 2004
  • Location: Round Lake, United States
  • FEI: 1416980
Add To Cart